1. Pink Sheet
  2. >>Compliance

Merger Enforcement: FTC And Justice Department Casting Wide Net In Considering Changes

 
• By Brenda Sandburg

Agencies seek public comment on how they can modernize merger guidelines to enforce antitrust laws. List of questions, including what types of evidence show that a merger could reduce competition, indicate pharma and other mergers will face greater scrutiny.

Mergers
FTC and DOJ are revising their merger guidelines • Source: Alamy

A year after the US Federal Trade Commission set its sights on pharmaceutical mergers, the agency has teamed up with the Department of Justice for a broad review of their merger guidelines. The new initiative once again shows that mergers in pharma and other industries may face additional hurdles.

On 18 January, the FTC and DOJ issued a request for information seeking public comment on how they can modernize enforcement of antitrust laws in mergers. The request includes...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Compliance

More from Pink Sheet

Non-User Fee Dollars Increased In US FDA’s Updated FY 2026 Budget Request

 
• By Derrick Gingery

The budget authority total, which is significantly higher than the amount floated in an April OMB draft document, suggests there may have been successful lobbying to increase FDA funding.

US ‘Most Favored Nation’ Pricing Could be Game Changer for Drug Access In Germany

 
• By Francesca Bruce

In this first in a series of articles looking at the potential impact of the MFN drug pricing policy on European pharmaceutical markets, EUCOPE’s Alexander Natz tells the Pink Sheet why the US policy underscores the importance of confidential net pricing.

ICH Targets RWE, Rare Diseases, Biosimilars, ATMPs In New Guideline Push

 
• By Vibha Sharma

The International Council for Harmonisation has identified four new topics that can benefit from global regulatory alignment, with timelines for initiating work to be determined later.